Revolutionizing Longevity with AI — Announcing the Rejuve.Bio Crowdsale

SingularityNET
SingularityNET
Published in
4 min readMar 5, 2024

--

Rejuve.Bio is excited to announce its next step toward innovating human longevity through the power of AI, and you can be a part of it!

Dear Singularitarians,

As we embark on a new era in health and longevity, SingularityNET stands at the pinnacle of AI-driven innovation.

Among the many projects within the ecosystem, Rejuve.Bio illuminates the unparalleled potential of AI to revolutionize modern medicine. Now, we have reached a significant milestone in its journey of innovation and discovery.

We are thrilled to announce the launch of Rejuve.Bio’s Crowd Fund Raise on the NetCapital platform. This launch provides a chance for members of the community to join forces with us in the integration of AI and medicine, as well as a call to collectively propel and be a part of the next step in healthcare evolution.

About Rejuve.Bio

Imagine a world where living longer means living better — where age isn’t a barrier but a challenge to overcome. A world where longevity is not just about extending our lifespans, but about enriching our lives. Rejuve.Bio is pioneering biotech by leveraging the power of AI against the complexities of genetics, reshaping our understanding of aging and opening up new possibilities for health and longevity.

Their mission is to leverage the power of AI to improve the results while reducing the costs and time of the drug discovery and therapeutics process; therefore extending human healthspan, redefining aging, and transforming lives.

Learn more about Rejuve.Bio’s mission on their website.

As a member of the SingularityNET community, you have the opportunity to be part of this exciting journey. Join Rejuve.Bio in redefining the limitations of human life, and partner with Rejuve.Bio in a future where healthy agelessness is within reach.

The Rejuve.Bio Opportunity: Shaping the Next Chapter of AI & Health with SingularityNET

Be at the forefront of AI innovation. You’ll be a part of the select few people actively contributing to some of the most avant-garde developments in AI and longevity research. The company’s prowess in combining rich cross-organism data, neural-symbolic AI, and other advanced technologies promises to radically change our understanding of aging and our approach to tackling age-related illnesses.

Connect with Visionaries: With the guidance of luminaries like Dr. Ben Goertzel, Kennedy Schaal, and a stellar team of professionals with expertise in various domains from genetics to AI, Rejuve.Bio has some of the industry’s most brilliant minds collaborating to redefine human healthspan and transform the future of aging research.

Shift the Aging Paradigm: As we move into an era where aging is seen less as a fact of life and more as a challenge to overcome, being a part of the Rejuve.Bio community means directly contributing to changing how the world perceives and approaches aging.

“AI is getting more and more powerful, and the ability of biologists to gather data from Human organisms and other model organisms like fruit flies, the ability to gather data is just increasing more and more. So, we’re really in an incredible time to be able to apply Advanced AI to this great diversity of data to discover a palette of incredible therapeutics. I’m just thrilled to be able to apply my mind together with the minds of the other incredible people we have in Rejuve Biotech to solve this problem that we all face and create therapeutics to radically increase human healthspan.”

— Dr. Ben Goertzel

Join the Crowdsale

Don’t miss this opportunity to create a better future — join Rejuve.Bio in the next stage of their growth, and work with us on our mission to unlock the true potential of AI and longevity.

Visit NetCapital.com/RejuveBiotech to learn more and participate in the crowdsale.

Joining the Rejuve.Bio mission means you’re becoming part of a global community passionate about driving AGI forward. As a member of this movement, you’ll be privy to exclusive insights within our community, encompassing regular updates, forums, events, and unparalleled opportunities to connect with industry pioneers and specialists.

Together, we have the opportunity to rewrite the narrative of aging, leveraging the power of AI to revolutionize the healthcare industry and redefine the very essence of human longevity.

Disclaimer: Newsletters published by SingularityNET are meant for informational purposes only and are not intended to serve as a recommendation to buy or sell any security in a self-directed account and are not an offer or sale of a security. Any investment is not directly managed by SingularityNET or Rejuve.Bio. All investments involve risk, and the past performance of a security or financial product does not guarantee future results or returns. Potential investors should seek professional advice and carefully review all documentation before making any investment decisions.

About SingularityNET

SingularityNET is a decentralized AI Platform and Marketplace for Artificial Intelligence (AI) services. Our mission is the creation of a decentralized, democratic, inclusive, and beneficial Artificial General Intelligence (AGI), democratizing access to AI and AGI technologies through:

  • Our Platform, where anyone can develop, share, and monetize AI algorithms, models, and data.
  • OpenCog Hyperon, our premier neural-symbolic AGI Framework, will be a core service for the next wave of AI innovation.
  • Our Ecosystem, developing advanced AI solutions across market verticals to revolutionize industries.

Stay Up to Date With the Latest News, Follow Us on:

--

--

The world's first decentralized Artificial Intelligence (AI) network